Affordable Access

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

Authors
  • Mohamed, Somaia
  • Osatuke, Katerine
  • Aslam, Muhammed
  • Kasckow, John
Type
Published Article
Journal
The American journal of geriatric pharmacotherapy
Publication Date
Sep 01, 2006
Volume
4
Issue
3
Pages
201–209
Identifiers
PMID: 17062320
Source
Medline
License
Unknown

Abstract

In this small study in elderly patients with comorbid MDD and GAD, treatment with escitalopram 10 to 20 mg/d for 12 weeks was associated with significant improvements in symptoms of depression and anxiety.

Report this publication

Statistics

Seen <100 times